NERV Instantâneo da Ação
Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$4.95
Capitalização de Mercado
$217M
P/E (TTM)
-0.1
EPS (TTM)
$-34.67
Receita (TTM)
$0
Rendimento div.
—
ROE
339.5%
Dívida/Capital
—
Intervalo 52 Semanas
$2 – $12
NERV Gráfico de Preço da Ação
OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Médias móveis e sobreposições
Volume
Osciladores
Momento e tendência
Configure
Desempenho de 10 Anos
Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido$0
2017-12-31→2024-12-31
EPS$-34.67
2019-12-31→2025-12-31
Fluxo de caixa livre—
2017-12-31→2017-12-31
Margens—
Avaliação
Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
NERV
Mediana de Pares
P/E (TTM)
-0.1
—
P/B
-1.5
1.4
Lucratividade
Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
NERV
Mediana de Pares
ROA
-434.3%
-58.9%
ROE
339.5%
-83.3%
Saúde financeira
Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
NERV
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
36.3
8.5
Quick Ratio (Índice de Liquidez Seca)
35.9
—
Crescimento
Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
NERV
Mediana de Pares
Métricas por Ação
EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação
Métrica
Tendência de 5 anos
NERV
Mediana de Pares
EPS (Diluted) (EPS (Diluído))
$-34.67
—
Eficiência de Capital
Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
NERV
Mediana de Pares
NERV Consenso dos analistas
Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA9 analistas
Compra forte
222,2%
Compra
444,4%
Manter
333,3%
Venda
00,0%
Venda forte
00,0%
Preço-alvo de 12 meses
3 analistas
· 2026-08-19
Mediana$10.00
← Abaixo de todos os alvos
$4.95
Mín$7.00
Máx$14.00
Alvo mediano$10.00
+102,2%
Alvo médio$10.33
+109,0%
Histórico de Lucros
EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.19%
Período
EPS Actual
EPS est.
Surpresa
30 de Junho de 2026
$-0.17
$-0.12
-0.05%
31 de Março de 2026
$-0.17
$-0.13
-0.04%
31 de Dezembro de 2025
$-0.64
$-0.31
-0.33%
30 de Junho de 2025
$-0.43
$-0.92
0.49%
31 de Março de 2025
$-0.50
$-1.09
0.59%
31 de Dezembro de 2024
$-0.56
$-1.07
0.51%
Comparação de pares (subindústria GICS)
Métricas chave vs pares do setor
Ticker
Capitalização de Mercado
P/E
Receita YoY
Margem Líquida
ROE
Margem Bruta
NERV
$174M
-0.1
—
—
339.5%
—
NBP
—
—
—
—
—
—
IMUX
—
-0.9
—
—
—
—
ORGO
$658M
34.5
17.0%
6.6%
13.9%
—
RNA
$10.91B
-14.5
72.1%
-3650.4%
-47.5%
—
IVVD
$697M
-8.2
110.5%
-98.2%
-36.9%
—
TNXP
$200M
-1.1
29.8%
-946.2%
-60.0%
—
WHWK
$114M
-7.3
-72.5%
-288.3%
-13.4%
—
PEPG
$448M
-3.1
—
—
-82.0%
—
KROS
$398M
8.9
—
35.7%
17.2%
—
DTIL
$100M
-1.2
-50.1%
-133.4%
-72.4%
—
Fundamentos Completos
Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados14
Dados anuais de Demonstração de Resultados para NERV
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
·
$0
$0
$0
·
$41M
$0
$0
$0
R&D Expense
$6M
$12M
$13M
$15M
$32M
$22M
$58M
$35M
$30M
SG&A Expense
$9M
$10M
$10M
$11M
$13M
$17M
$18M
$17M
$11M
Operating Expenses
$15M
$22M
$23M
$25M
$45M
$39M
$76M
$52M
$41M
Operating Income
$-15M
$-22M
$-23M
$-25M
$-45M
$2M
$-76M
$-52M
$-41M
Interest Income
$948.1K
$1M
$1M
$556.9K
$16.5K
$161.2K
$1M
$2M
$941.8K
Pretax Income
·
·
·
$-32M
$-52M
$2M
$-74M
$-50M
$-41M
Income Tax
·
·
·
·
$-2M
·
$-2M
$0
$-9M
Net Income
$-293M
$1M
$-30M
$-32M
$-50M
$2M
$-72M
$-50M
$-32M
EPS (Basic)
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
$0.05
$-1.85
·
·
EPS (Diluted)
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
$0.05
$-1.85
·
·
Shares (Basic)
8,463,581
7,568,981
6,506,372
5,340,194
5,340,196
40,823,717
39,014,302
·
·
Shares (Diluted)
8,463,581
7,573,763
6,506,372
5,340,194
5,340,196
40,916,871
39,014,302
·
·
EBITDA
$-15M
·
·
·
$-45M
$2M
$-76M
$-52M
$-41M
Balanço Patrimonial22
Dados anuais de Balanço Patrimonial para NERV
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
Cash & Equivalents
$82M
$21M
$41M
$36M
$61M
$25M
$21M
$50M
$26M
Short-term Investments
·
·
·
·
·
·
$24M
$38M
$102M
Prepaid Expense
$697.7K
$806.9K
$989.9K
$848.1K
$1M
$2M
$1M
$2M
$1M
Current Assets
$83M
$22M
$42M
$40M
$62M
$27M
$47M
$90M
$130M
PP&E (Net)
$0
$5.4K
$10.9K
$16.3K
·
·
$16.0K
$33.5K
$50.9K
Goodwill
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
Intangibles
·
·
·
·
·
$15M
$15M
$34M
$34M
Other Non-current Assets
·
·
·
·
·
$14.8K
$14.8K
$14.8K
$14.8K
Total Assets
$98M
$37M
$57M
$55M
$77M
$58M
$77M
$139M
$184M
Accounts Payable
$639.7K
$2M
$2M
$969.7K
$2M
$995.6K
$2M
$2M
$1M
Short-term Debt
·
·
·
·
·
·
·
·
$4M
Current Liabilities
$2M
$3M
$3M
$1M
$3M
$3M
$7M
$4M
$7M
Capital Leases
·
·
·
·
·
·
$111.2K
·
·
Deferred Tax
·
·
·
·
·
$2M
$2M
$4M
$4M
Other Non-current Liabilities
·
·
·
·
·
·
·
$29.0K
$29.9K
Total Liabilities
$234M
$63M
$85M
$75M
$69M
$5M
$50M
$49M
$52M
Total Debt
·
·
·
·
·
·
·
·
$4M
Common Stock
$4.3K
$699
$699
$534
$534
$4.3K
$3.9K
$3.9K
$3.9K
Retained Earnings
$-689M
$-395M
$-397M
$-367M
$-335M
$-285M
$-287M
$-215M
$-164M
Stockholders' Equity
$-141M
$-26M
$-28M
$-20M
$8M
$53M
$28M
$90M
$132M
Liabilities + Equity
$98M
$37M
$57M
$55M
$77M
$58M
$77M
$139M
$184M
Shares Outstanding
43,274,398
6,993,406
6,993,406
5,340,193
5,340,196
5,340,196
39,084,121
38,937,971
38,749,343
Fluxo de Caixa12
Dados anuais de Fluxo de Caixa para NERV
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
D&A
$5.4K
$5.4K
$5.4K
·
·
$16.0K
$17.5K
$17.5K
$11.1K
Stock-based Comp
$1M
$1M
$2M
$4M
$5M
$10M
$9M
$8M
$5M
Other Non-cash
·
·
·
·
·
$-45M
$20M
$29.4K
$30M
Operating Cash Flow
$-14M
$-20M
$-15M
$-25M
$-25M
$-34M
$-43M
$-42M
$3M
CapEx
·
·
·
$16.3K
·
·
·
·
$52.4K
Investing Cash Flow
$0
$0
$0
$-16.3K
·
$25M
$14M
$69M
$-107M
Stock Repurchased
·
·
·
·
·
·
·
·
$389
Net Stock Activity
·
·
·
·
·
·
·
·
$-389
Financing Cash Flow
$74M
·
$20M
$-5
$60M
$13M
$525.0K
$-3M
$47M
Net Change in Cash
$61M
$-20M
$5M
$-25M
$35M
$4M
$-29M
$24M
$-57M
Taxes Paid
$0
$0
·
·
·
·
·
·
·
Free Cash Flow
·
·
·
·
·
·
·
·
$3M
Lucratividade7
Dados anuais de Lucratividade para NERV
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
Operating Margin
·
·
·
·
·
4.5%
·
·
·
Net Margin
·
·
·
·
·
4.7%
·
·
·
Pretax Margin
·
·
·
·
·
4.7%
·
·
·
EBITDA Margin
·
·
·
·
·
4.5%
·
·
·
ROA
-434.3%
·
·
·
-74.1%
2.9%
-66.6%
-31.1%
-19.9%
ROE
339.5%
·
·
·
-276.8%
3.5%
-173.3%
-52.3%
-24.1%
ROIC
·
·
·
·
-549.0%
·
-264.8%
-57.3%
-23.4%
Liquidez e Solvência3
Dados anuais de Liquidez e Solvência para NERV
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
Current Ratio
36.3
·
·
·
22.1
8.7
7.1
24.9
18.9
Quick Ratio
35.9
·
·
·
21.6
8.0
6.9
24.4
18.7
Debt / Equity
·
·
·
·
·
·
·
·
0.0
Eficiência1
Dados anuais de Eficiência para NERV
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
Asset Turnover
·
·
·
·
·
0.6
0.0
0.0
0.0
Por Ação5
Dados anuais de Por Ação para NERV
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
Book Value / Share
$-3.25
·
·
·
$0.19
$1.23
$0.71
$2.32
$3.40
Revenue / Share
·
·
·
·
·
$1.01
·
·
·
Cash Flow / Share
$-1.60
·
·
·
$-0.58
$-0.83
·
·
·
Cash / Share
$1.90
·
·
·
$1.42
$0.59
$0.55
$1.29
$0.67
EPS (TTM)
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
$0.05
$-1.85
·
·
Avaliação (TTM)13
Dados anuais de Avaliação (TTM) para NERV
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue TTM
·
$0
$0
$0
·
$41M
$0
$0
$0
Net Income TTM
$-293M
$1M
$-30M
$-32M
$-50M
$2M
$-72M
$-50M
$-32M
Market Cap
$174M
·
·
·
$274M
$800M
$2.22B
$2.10B
$1.88B
Enterprise Value
·
·
·
·
·
·
·
·
$1.75B
P/E
-0.1
11.7
-1.3
-0.3
-0.7
374.4
-30.7
·
·
P/S
·
·
·
·
·
19.4
·
·
·
P/B
-1.2
·
·
·
34.3
15.2
80.0
23.3
14.3
P / Tangible Book
·
·
·
·
·
35.4
·
·
·
P / Cash Flow
-12.9
·
·
·
-11.1
-23.6
-51.2
-50.1
606.4
P / FCF
·
·
·
·
·
·
·
·
616.8
EV / EBITDA
·
·
·
·
·
·
·
·
-42.5
EV / FCF
·
·
·
·
·
·
·
·
576.0
Earnings Yield
-862.4%
8.6%
-75.0%
-378.0%
-145.9%
0.27%
-3.2%
·
·
Demonstração de Resultados11
Dados trimestrais de Demonstração de Resultados para NERV
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
R&D Expense
$7M
$5M
$2M
$925.4K
$1M
$1M
$2M
$2M
$4M
$4M
$5M
$3M
$2M
$3M
$3M
$2M
SG&A Expense
$3M
$11M
$3M
$2M
$2M
$3M
$3M
$2M
$2M
$3M
$2M
$3M
$3M
$3M
$2M
$3M
Operating Expenses
$11M
$17M
$5M
$3M
$3M
$4M
$5M
$4M
$6M
$7M
$7M
$6M
$5M
$5M
$5M
$5M
Operating Income
$-11M
$-17M
$-5M
$-3M
$-3M
$-4M
$-5M
$-4M
$-6M
$-7M
$-7M
$-6M
$-5M
$-5M
$-5M
$-5M
Interest Income
$569.6K
$629.6K
$546.5K
$106.6K
$136.7K
$158.3K
$239.7K
$314.0K
$360.8K
$357.9K
$358.9K
$348.7K
$365.6K
$364.2K
$297.1K
$180.1K
Net Income
$17M
$-125M
$-284M
$-3M
$-3M
$-4M
$-4M
$23M
$-8M
$-9M
$-9M
$-8M
$-6M
$-7M
$-7M
$-7M
EPS (Basic)
$0.36
$-2.86
$-33.38
$-0.36
$-0.43
$-0.50
$-0.56
$2.97
$-1.09
$-1.13
$-1.15
$-1.03
$-1.12
$-1.31
$-1.26
$-1.29
EPS (Diluted)
$-0.14
$-2.86
$-33.38
$-0.36
$-0.43
$-0.50
$-0.56
$2.97
$-1.09
$-1.13
$-1.15
$-1.03
$-1.12
$-1.31
$-1.26
$-1.29
Shares (Basic)
46,599,044
43,900,426
-14,243,362
7,568,981
7,568,981
7,568,981
-15,137,962
7,568,981
7,568,981
7,568,981
-11,913,965
7,568,981
5,511,163
5,340,193
-10,680,391
5,340,193
Shares (Diluted)
79,104,585
43,900,426
-14,243,362
7,568,981
7,568,981
7,568,981
-15,133,180
7,568,981
7,568,981
7,568,981
-11,913,965
7,568,981
5,511,163
5,340,193
-10,680,391
5,340,193
EBITDA
$-11M
$-17M
·
$-3M
$-3M
$-4M
·
$-4M
$-6M
$-7M
·
$-6M
$-5M
$-5M
·
$-5M
Balanço Patrimonial15
Dados trimestrais de Balanço Patrimonial para NERV
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Cash & Equivalents
$25M
$33M
$82M
$12M
$15M
$17M
$21M
$27M
$31M
$35M
$41M
$47M
$52M
$36M
$36M
$40M
Short-term Investments
$51M
$45M
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Prepaid Expense
$4M
$941.9K
$697.7K
$633.5K
$199.6K
$534.8K
$806.9K
$1M
$428.0K
$702.5K
$989.9K
$1M
$329.2K
$596.0K
$848.1K
$1M
Current Assets
$80M
$79M
$83M
$13M
$16M
$18M
$22M
$28M
$31M
$36M
$42M
$48M
$52M
$37M
$40M
$45M
PP&E (Net)
·
·
$0
$1.4K
$2.7K
$4.1K
$5.4K
$6.8K
$8.2K
$9.5K
$10.9K
$12.2K
$13.6K
$15.0K
$16.3K
·
Goodwill
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
Total Assets
$95M
$94M
$98M
$28M
$30M
$33M
$37M
$43M
$46M
$51M
$57M
$63M
$67M
$52M
$55M
$60M
Accounts Payable
$1M
$2M
$639.7K
$944.5K
$896.8K
$639.9K
$2M
$553.2K
$828.3K
$1M
$2M
$1M
$298.3K
$961.0K
$969.7K
$532.9K
Current Liabilities
$4M
$4M
$2M
$3M
$3M
$2M
$3M
$4M
$4M
$3M
$3M
$3M
$2M
$3M
$1M
$2M
Total Liabilities
$297M
$343M
$234M
$63M
$63M
$62M
$63M
$64M
$91M
$87M
$85M
$83M
$80M
$78M
$75M
$74M
Common Stock
$4.7K
$4.4K
$4.3K
$699
$699
$699
$699
$699
$699
$699
$699
$699
$699
$534
$534
$534
Retained Earnings
$-797M
$-814M
$-689M
$-405M
$-402M
$-399M
$-395M
$-391M
$-414M
$-405M
$-397M
$-388M
$-380M
$-374M
$-367M
$-360M
Stockholders' Equity
$-213M
$-254M
$-141M
$-35M
$-32M
$-29M
$-26M
$-22M
$-44M
$-37M
$-28M
$-20M
$-13M
$-27M
$-20M
$-14M
Liabilities + Equity
$95M
$94M
$98M
$28M
$30M
$33M
$37M
$43M
$46M
$51M
$57M
$63M
$67M
$52M
$55M
$60M
Shares Outstanding
47,227,259
43,841,998
43,274,398
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
5,340,193
5,340,193
5,340,193
Fluxo de Caixa6
Dados trimestrais de Fluxo de Caixa para NERV
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
D&A
·
·
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
·
·
Stock-based Comp
$2M
$9M
$459.0K
$272.9K
$298.2K
$297.2K
$249.7K
$307.7K
$329.3K
$438.8K
$611.1K
$371.9K
$608.9K
$376.5K
$947.7K
$1M
Operating Cash Flow
$-13M
$-5M
$-4M
$-3M
$-2M
$-4M
$-5M
$-4M
$-4M
$-6M
$-6M
$-5M
$-4M
$-115.4K
$-4M
$-10M
Investing Cash Flow
$-5M
$-45M
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$-16.3K
·
Financing Cash Flow
$10M
$1M
$74M
$-45.2K
$0
$0
·
·
$0
$0
$0
$-86.7K
$20M
$0
$0
$0
Net Change in Cash
$-8M
$-50M
$70M
$-3M
$-2M
$-4M
$-5M
$-4M
$-4M
$-6M
$-6M
$-5M
$16M
$-115.4K
$-4M
$-10M
Lucratividade2
Dados trimestrais de Lucratividade para NERV
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
ROA
27.8%
-197.8%
·
-7.7%
-8.5%
-9.0%
·
42.5%
-14.5%
-16.8%
·
-12.7%
-9.4%
-11.4%
·
-8.8%
ROE
-14.2%
88.6%
·
9.8%
8.5%
11.4%
·
-107.9%
28.9%
27.1%
·
45.6%
59.3%
51.0%
·
-99.8%
Liquidez e Solvência2
Dados trimestrais de Liquidez e Solvência para NERV
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Current Ratio
20.1
17.6
·
4.9
6.1
9.2
·
6.2
7.5
12.6
·
14.4
27.4
14.7
·
20.4
Quick Ratio
19.0
17.4
·
4.6
6.0
8.9
·
5.9
7.3
12.3
·
14.0
27.1
14.4
·
18.3
Por Ação4
Dados trimestrais de Por Ação para NERV
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Book Value / Share
$-4.52
$-5.79
·
$-4.94
$-4.59
$-4.17
·
$-3.10
$-6.36
$-5.23
·
$-2.87
$-1.79
$-4.98
·
$-2.67
Cash Flow / Share
·
$-0.12
·
·
·
$-0.54
·
·
·
$-0.81
·
·
·
$-0.02
·
·
Cash / Share
$0.52
$0.74
·
$1.76
$2.18
$2.47
·
$3.79
$4.42
$4.98
·
$6.71
$7.41
$6.74
·
$7.53
EPS (TTM)
$-3.79
$-4.15
·
$1.68
$0.95
$0.25
·
$-0.28
$-4.37
$-4.59
·
$-4.75
$-5.35
$-6.06
·
$-6.47
Avaliação (TTM)6
Dados trimestrais de Avaliação (TTM) para NERV
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Net Income TTM
$-114M
$-135M
·
$13M
$7M
$2M
·
$-2M
$-31M
$-30M
·
$-28M
$-29M
$-32M
·
$-35M
Market Cap
$262M
$264M
·
$15M
$12M
$12M
·
$19M
$22M
$18M
·
$48M
$64M
$9M
·
$49M
P/E
-1.5
-1.5
·
1.3
1.8
6.8
·
-9.5
-0.7
-0.6
·
-1.5
-1.7
-0.3
·
-1.4
P/B
-1.2
-1.0
·
-0.4
-0.4
-0.4
·
-0.9
-0.5
-0.5
·
-2.4
-5.1
-0.3
·
-3.5
P / Cash Flow
·
-48.7
·
·
·
-2.9
·
·
·
-3.0
·
·
·
-74.0
·
·
Earnings Yield
-68.3%
-68.9%
·
79.8%
55.2%
14.7%
·
-10.5%
-137.0%
-177.9%
·
-68.8%
-58.5%
-378.8%
·
-70.1%
Demonstrações Financeiras
Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Receita
—
$0
$0
$0
—
Lucro líquido
$-293M
$1M
$-30M
$-32M
$-50M
EPS Diluído
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
Balanço Patrimonial
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Índice de liquidez corrente
36.3
—
—
—
22.1
Índice de Liquidez Seca
35.9
—
—
—
21.6
Minhas Métricas
Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F)
60 declarantes · $216.5M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições
Posições encerradas
Aumentou
Diminuído
Variação líquida de ações
27
(+13 vs trimestre anterior)
7
(+4 vs trimestre anterior)
10
(+2 vs trimestre anterior)
11
(+3 vs trimestre anterior)
+1.7M
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+
5 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
Declarante
Declarado
Participação
Status
Propósito
Declaração
Boehringer AG, Boehringer Ingelheim International GmbH
×2 declarações
INDEX VENTURE ASSOCIATES III LIMITED, INDEX VENTURES III (JERSEY) L.P., INDEX VENTURES III (DELAWARE) L.P., INDEX VENTURES III PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., INDEX VENTURE ASSOCIATES IV LIMITED, INDEX VENTURES IV (JERSEY) L.P., INDEX VENTURES IV PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., INDEX VENTURE ASSOCIATES V LIMITED, INDEX VENTURES V (JERSEY) L.P., INDEX VENTURES V PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., YUCCA (JERSEY) SLP
×5 declarações
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs
Detido por 11 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.